US Stock MarketDetailed Quotes
LVCLY ALGORAE PHARMACEUTICALS LTD SPON ADR EA REPR 10 ORD NPV
- 0.030600
- 0.0000000.00%
15min DelayClose Jul 11 09:30 ET
5.16MMarket Cap-3.40P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.030600Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)168.74MShares0.05960052wk High2.04P/B5.16MFloat Cap0.02100052wk Low--Dividend TTM168.74MShs Float0.119300Historical High--Div YieldTTM0.00%Amplitude0.021000Historical Low--Avg Price1Lot Size
ALGORAE PHARMACEUTICALS LTD SPON ADR EA REPR 10 ORD NPV Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -62.69%39.5K | -91.45%105.86K | 2,422.30%1.24M | -101.78%-53.32K | 1,302.35%3M | 22.99%-249.26K | -1,062.40%-323.68K | -1,232.34%-27.85K | 89.55%-2.09K | |
| Net PPE purchase and sale | ---- | ---3.8K | ---- | 989.16%91.78K | -245.22%-10.32K | 98.80%-2.99K | -36.21%-249.26K | -557.20%-183K | -1,232.34%-27.85K | 89.55%-2.09K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---42.99K | ---- | ---- | ---99.36K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --3M | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | -90.77%105.86K | --1.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | --43.3K | ---- | ---- | ---- | ---- | ---- | ---41.32K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | -62.69%39.5K | -91.45%105.86K | 2,422.30%1.24M | -101.78%-53.32K | 1,302.35%3M | 22.99%-249.26K | -1,062.40%-323.68K | -1,232.34%-27.85K | 89.55%-2.09K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -60.52%1.85M | 10,621.72%4.69M | 11.35%-44.54K | -50.24K | -99.47%31.3K | 62.35%5.93M | -10.12%3.65M | 4.07M | ||
| Net issuance payments of debt | ---- | --2.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | -24.76%2.15M | --2.86M | ---- | ---- | ---- | -99.47%31.3K | 62.35%5.93M | -10.12%3.65M | --4.07M | ---- |
| Net other financing activities | 35.01%-299.07K | -933.31%-460.21K | 11.35%-44.54K | ---50.24K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -60.52%1.85M | 10,621.72%4.69M | 11.35%-44.54K | ---50.24K | ---- | -99.47%31.3K | 62.35%5.93M | -10.12%3.65M | --4.07M | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 170.18%4.24M | -47.08%1.57M | -39.59%2.96M | -28.47%4.91M | -8.88%6.86M | 42.02%7.53M | 3.07%5.3M | 12.95%5.14M | 1.12%4.55M | 42.08%4.5M |
| Current changes in cash | -105.07%-136.05K | 291.64%2.68M | 27.14%-1.4M | 5.97%-1.92M | -277.10%-2.04M | -123.42%-542K | 1,230.97%2.31M | -61.44%173.86K | 633.45%450.93K | -106.42%-84.53K |
| Effect of exchange rate changes | 161.57%8.27K | -415.53%-13.43K | 120.08%4.26K | -123.51%-21.19K | 171.33%90.14K | -46.92%-126.37K | -441.30%-86.01K | -111.46%-15.89K | 2.86%138.7K | 693.22%134.85K |
| End cash Position | -3.01%4.11M | 170.18%4.24M | -47.08%1.57M | -39.59%2.96M | -28.47%4.91M | -8.88%6.86M | 42.02%7.53M | 3.07%5.3M | 12.95%5.14M | 1.12%4.55M |
| Free cash flow | 2.92%-1.99M | -39.99%-2.05M | 53.00%-1.46M | -52.15%-3.11M | 42.80%-2.04M | 1.27%-3.57M | -5.23%-3.62M | 4.86%-3.44M | -4,176.75%-3.62M | -106.42%-84.53K |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Heat List
US
Overall
Symbol
Price
% Chg
No Data